Safety Study of New Drug ATH-097 in Healthy Adults
This is an early-stage safety study testing a new experimental drug called ATH-097 in healthy volunteers. Researchers will give increasing doses to small groups to learn how the drug is tolerated and processed by the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 55 years old
- Have a healthy weight (BMI between 18.5 and 29.9)
- Be in generally good health with no serious medical conditions
- Not have participated in another drug trial in the past 28 days
- Not be pregnant, planning pregnancy, or nursing (women); use effective birth control if sexually active
- Not smoke, use recreational drugs, or drink heavily; limit caffeine and alcohol
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This trial tests a new drug called MTX-101 in healthy volunteers to see if it is safe and how the body processes it. It helps determine the right dose before testing in patients with certain conditions.
This is an early-stage safety study testing a new drug called NHL907 in healthy volunteers. Researchers want to understand how the drug is processed by the body and confirm it is safe.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
This study tests a new medicine, ART105, in healthy adults to see if it is safe and how the body handles it. It is an early-stage trial, so it may not directly help you, but you would be contributing to medical research.
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
Hear when a new This is a Phase I Study Conducted in Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.